A case report highlights the delayed diagnosis of tumor-induced osteomalacia due to overlooked hypophosphatemia linked to excess fibroblast growth factor 23. This underscores the need for increased awareness and diagnostic vigilance in similar cases.
tumor induced osteomalacia caused by fibroblast growth factor 23 excess delayed diagnosis resulting from overlooked hypophosphatemia a case report
Original title: “Tumor-induced osteomalacia caused by fibroblast growth factor 23 excess : Delayed diagnosis resulting from overlooked hypophosphatemia-A case report.”